Rafferty Asset Management’s Immunomedics Inc IMMU Stock Holding History

Rafferty Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-46,963	Closed	-$3.99M	–	1072
2020 Q3	$3.99M	Buy	46,963 +16,087	+52%	+$814K	0.05%	217
2020 Q2	$1.09M	Buy	30,876 +10,933	+55%	+$320K	0.02%	518
2020 Q1	$269K	Sell	19,943 -149,526	-88%	-$2.52M	0.01%	467
2019 Q4	$3.59M	Sell	169,469 -134,283	-44%	-$2.37M	0.06%	192
2019 Q3	$4.03M	Sell	303,752 -96,258	-24%	-$1.41M	0.06%	182
2019 Q2	$5.55M	Buy	400,010 +96,683	+32%	+$1.45M	0.1%	139
2019 Q1	$5.83M	Buy	+303,327	New	+$4.89M	0.09%	114

Rafferty Asset Management's IMMU Position: Q4 2020 in Review

Rafferty Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 46,963 shares — an estimated $3.99M sold.

Rafferty Asset Management first reported a position in IMMU in Q1 2019 and held it in 7 quarters. The position peaked at $5.83M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Rafferty Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Rafferty Asset Management sold 46,963 Immunomedics Inc shares in Q4 2020, an estimated $3.99M.
Rafferty Asset Management first reported a position in Immunomedics Inc in Q1 2019 and held it in 7 quarters.
Rafferty Asset Management's Immunomedics Inc position peaked at $5.83M in Q1 2019.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Rafferty Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.